Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma

Clinical trial NCT06438822 · RECRUITING

Trial details

NCT number: NCT06438822
Sponsor: West China Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cholangiocarcinoma

Start date: 2024-08-30
Primary completion: 2026-08-30
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.